Back to MW MARSHALL WACE, LLP

RCELRCEL
Showing 5 of 13 quarters

Position history for MWMARSHALL WACE, LLP's holdings in AVITA MEDICAL INC

MARSHALL WACE, LLP holds 52,562 shares of RCEL (AVITA MEDICAL INC), worth $194,480 as of 2026-Q1. This is a new position. RCEL represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$194,480

Current Shares

52,562

Total Value Change

-$734,229

Total Shares Change

-61,530

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
New
52,562
-
$194,4800.0%$4.81
32
2025-Q4
Exited
0
-100.0%
$00.0%$3.45
0
2025-Q3
Decreased
42,807
-44.3%
$218,7440.0%$5.37
0
2025-Q2
Decreased
76,825
-32.7%
$406,4050.0%$5.45
0
2025-Q1
New
114,092
-
$928,7090.0%$8.73
35

Other major holders of RCEL: BlackRock Finance, Inc., BlackRock, Inc., VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used